The Hirshberg Foundation is delighted that Dr. Mark Girgis will share the latest information in the field of pancreatic cancer detection and treatment at the 16th Annual Symposium on Pancreatic Cancer.
Dr. Girgis returns to our Symposium stage to present his report on the progress being made for the early detection and treatment of pancreatic cancer. Dr. Girgis is no stranger to our Symposium having presented, Advances in Pancreatic Surgery where he discussed the latest in robotic surgery. In addition, he participated in our Patient & Family Webinar Series with the talk, Pancreatic Cancer: Advances in Research and Patient Care. A surgeon as well as a researcher, we look forward to hearing the latest developments towards improving patient outcomes.
Dr. Mark Girgis is an Assistant Professor of Surgery at the David Geffen School of Medicine at UCLA. He also has a joint appointment at the Greater Los Angeles VA Medical Center. His interests include robotic and minimally invasive approaches to surgical oncology and more specifically on pancreatic diseases in his clinical practice as well as research endeavors. He received advanced training in robotic surgery and surgical oncology in his fellowship at the University of Pittsburgh. He is one member of the group of pancreas surgeons at UCLA that provide the highest level of care for their patients. He is committed to the improvement of cancer care through innovative technological advancements as well as ground breaking research. His research endeavors focus on developing novel peptides targeting pancreas cancer for radioligand therapy and is part of a multidisciplinary group that collaborates on a variety of projects centered on developing new therapies for cancer patients.
A highly requested topic, we are grateful to have Dr. Girgis provide us with a Pancreatic Cancer Progress Report at the 16th Annual Symposium.
